FI963452A - Menetelmä epoxidin valmistamiseksi - Google Patents

Menetelmä epoxidin valmistamiseksi Download PDF

Info

Publication number
FI963452A
FI963452A FI963452A FI963452A FI963452A FI 963452 A FI963452 A FI 963452A FI 963452 A FI963452 A FI 963452A FI 963452 A FI963452 A FI 963452A FI 963452 A FI963452 A FI 963452A
Authority
FI
Finland
Prior art keywords
epoxide
preparing epoxide
preparing
renin
proteases
Prior art date
Application number
FI963452A
Other languages
English (en)
Swedish (sv)
Other versions
FI120259B (fi
FI963452A0 (fi
Inventor
David Askin
Kan K Eng
Peter E Maligres
Paul J Reider
Kai Rossen
Ralph P Volante
Veena Upadhyay
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22764868&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963452(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI963452A0 publication Critical patent/FI963452A0/fi
Publication of FI963452A publication Critical patent/FI963452A/fi
Application granted granted Critical
Publication of FI120259B publication Critical patent/FI120259B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI963452A 1994-03-04 1996-09-03 Menetelmä epoksidin valmistamiseksi FI120259B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20607494A 1994-03-04 1994-03-04
US20607494 1994-03-04
PCT/US1995/002347 WO1995023797A1 (en) 1994-03-04 1995-02-27 Process for making an epoxide
US9502347 1995-02-27

Publications (3)

Publication Number Publication Date
FI963452A0 FI963452A0 (fi) 1996-09-03
FI963452A true FI963452A (fi) 1996-09-03
FI120259B FI120259B (fi) 2009-08-31

Family

ID=22764868

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963452A FI120259B (fi) 1994-03-04 1996-09-03 Menetelmä epoksidin valmistamiseksi

Country Status (25)

Country Link
EP (1) EP0748319B1 (fi)
JP (1) JP3871705B2 (fi)
KR (1) KR100387741B1 (fi)
CN (1) CN1066728C (fi)
AT (1) ATE210662T1 (fi)
AU (1) AU690231B2 (fi)
BR (1) BR9506977A (fi)
CA (1) CA2183976C (fi)
CZ (1) CZ291816B6 (fi)
DE (1) DE69524578T2 (fi)
DK (1) DK0748319T3 (fi)
ES (1) ES2167419T3 (fi)
FI (1) FI120259B (fi)
HR (1) HRP950096B1 (fi)
HU (1) HU222750B1 (fi)
MX (1) MX9603871A (fi)
NZ (1) NZ281866A (fi)
PT (1) PT748319E (fi)
RO (1) RO117696B1 (fi)
RU (1) RU2137769C1 (fi)
SK (1) SK283067B6 (fi)
TW (1) TW380137B (fi)
UA (1) UA45968C2 (fi)
WO (1) WO1995023797A1 (fi)
YU (1) YU49010B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728840A (en) * 1994-03-04 1998-03-17 Merck & Co., Inc. Process for making an epoxide
TW415948B (en) * 1995-10-30 2000-12-21 Merck & Co Inc Process for synthesizing epoxide and halohydrin
US5981759A (en) * 1997-06-20 1999-11-09 Merck & Co., Inc. Process for indinavir intermediate
HUE034863T2 (en) 2005-11-09 2018-03-28 Onyx Therapeutics Inc Compound for inhibiting enzyme
EP2484688B1 (en) 2006-06-19 2016-06-08 Onyx Therapeutics, Inc. Peptide epoxyketones for proteasome inhibition
MX2010003732A (es) 2007-10-04 2010-08-09 Onyx Therapeutics Inc Inhibidores de peptido cetona epoxi de proteasa cristalina y la sintesis de ceto-epoxidos de aminoacido.
UA104600C2 (ru) 2008-10-21 2014-02-25 Онікс Терап'Ютікс, Інк. Комбинированная терапия с применением пептида эпоксикетона
AR075899A1 (es) 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
JP5919196B2 (ja) 2009-11-13 2016-05-18 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 転移抑制のためのペプチドエポキシケトンの使用
US9359398B2 (en) 2010-03-01 2016-06-07 Onyx Therapeutics, Inc. Compounds for immunoproteasome inhibition
KR20130108975A (ko) * 2010-04-30 2013-10-07 인디애나 유니버시티 리서치 앤드 테크놀로지 코포레이션 리네졸리드의 제조 방법
US20140105921A1 (en) 2012-07-09 2014-04-17 Onyx Therapeutics, Inc. Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
CN104692987B (zh) * 2015-01-22 2017-05-17 北京大学 卤代醇及其衍生物的廉价高效合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072237A1 (en) * 1991-07-02 1993-01-03 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides
DK0541168T3 (da) * 1991-11-08 1998-05-11 Merck & Co Inc HIV-proteaseinhibitorer, som er egnede til behandling af AIDS

Also Published As

Publication number Publication date
JP3871705B2 (ja) 2007-01-24
HRP950096B1 (en) 2002-06-30
RO117696B1 (ro) 2002-06-28
CZ291816B6 (cs) 2003-06-18
PT748319E (pt) 2002-05-31
FI120259B (fi) 2009-08-31
KR100387741B1 (ko) 2003-10-04
YU14595A (sh) 1997-12-05
UA45968C2 (uk) 2002-05-15
EP0748319A1 (en) 1996-12-18
JPH09509929A (ja) 1997-10-07
ATE210662T1 (de) 2001-12-15
KR970701714A (ko) 1997-04-12
RU2137769C1 (ru) 1999-09-20
FI963452A0 (fi) 1996-09-03
CZ254396A3 (en) 1997-01-15
EP0748319B1 (en) 2001-12-12
DK0748319T3 (da) 2002-03-18
CN1146768A (zh) 1997-04-02
TW380137B (en) 2000-01-21
YU49010B (sh) 2003-04-30
ES2167419T3 (es) 2002-05-16
DE69524578D1 (de) 2002-01-24
CA2183976C (en) 2005-02-01
CA2183976A1 (en) 1995-09-08
HU9602412D0 (en) 1996-11-28
HUT75611A (en) 1997-05-28
SK112296A3 (en) 1997-02-05
DE69524578T2 (de) 2002-07-18
AU690231B2 (en) 1998-04-23
WO1995023797A1 (en) 1995-09-08
HRP950096A2 (en) 1997-06-30
HU222750B1 (hu) 2003-09-29
SK283067B6 (sk) 2003-02-04
CN1066728C (zh) 2001-06-06
MX9603871A (es) 1997-07-31
AU1882895A (en) 1995-09-18
NZ281866A (en) 1998-05-27
BR9506977A (pt) 1997-09-02

Similar Documents

Publication Publication Date Title
DK0443449T3 (da) Fremgangsmåde til fremstilling af oxetanoner
FI963452A (fi) Menetelmä epoxidin valmistamiseksi
YU27304A (sh) Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova
UA50730C2 (uk) Спосіб одержання 1-(тіометил)циклопропаноцтової кислоти та проміжних сполук для її одержання
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
WO2001057014A3 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
ATE239716T1 (de) Synthese von 3,6-dialkyl-5,6-dihydro-4-hydroxy-2h-pyran-2-on
AR000813A1 (es) Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas
YU45896A (sh) Postupak za dobijanje epoksida
ATE233249T1 (de) Verfahren zur herstellung von hiv protease inhibitoren
LV12825B (en) Process for making hiv protease inhibitors
EA199900772A1 (ru) Способ селективного эпоксидирования для получения лекарственных соединений
HUP9903318A2 (hu) Intermedierek taxol előállítására
HUP9904510A2 (hu) Benzotiofének előállítására szolgáló eljárás
GB2369356B (en) Process
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
TW200611691A (en) Retroviral protease inhibiting compounds

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120259

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

MM Patent lapsed